HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods
- PMID: 21690244
- DOI: 10.1136/jcp.2011.089847
HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods
Abstract
These guidelines supplement existing guidelines on HER2 testing by immunohistochemistry and in-situ hybridisation(ISH) methods in the UK. They provide a specific focus on aspects of guidance relevant to HER2 ISH testing methods, both fluorescent and chromogenic. They are formulated to give advice on methodology, interpretation and quality control for ISH-based testing of HER2 status in common tumour types, including both breast and gastric tumours. The aim is to ensure that all ISH-based testing is accurate, reliable and timely.
Comment in
-
HER2 testing recommendations in the UK: dual- or single-colour in-situ hybridisation?J Clin Pathol. 2012 Apr;65(4):379. doi: 10.1136/jclinpath-2011-200467. Epub 2011 Oct 26. J Clin Pathol. 2012. PMID: 22031588 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous